{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:16:48Z","timestamp":1788243408741,"version":"build-2803163510"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to integrate clinical indicators with peripheral blood T-cell subsets to develop a prediction model for ulcerative colitis (UC), and to facilitate precise subtyping and individualized treatment decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 346 UC patients (June 2023\u2013June 2025) was randomly assigned to training (n=242) and validation (n=104) sets at a 7:3 ratio. Univariate analysis, Least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression to identify independent influencing factors. Machine learning models\u2014random forest (RF), gradient boosting, and logistic regression\u2014were constructed using the selected core variables. Model discrimination, calibration, and clinical utility were assessed using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>According to week-14 response criteria, the training set comprised 158 responders (65.3%) and 84 non-responders (34.7%). Six indicators significantly associated with treatment response: albumin, C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6), CD3+CD4+CD25+\/CD3+CD4+ T-lymphocyte ratio, and CD4\/CD8 ratio were as independent influencing factors. Among the models, RF exhibited the highest numerical AUC, with an AUC of 0.852 in the training set and 0.804 in the validation set. The calibration curve demonstrated good agreement between predicted and actual risks. DCA indicated higher net clinical benefit within a risk threshold range of 0.1\u20130.8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A predictive model for UC treatment response based on clinical indicators and peripheral blood T-cell subsets was constructed and validated, and may serves as an exploratory tool for individualized treatment decisions in UC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1905745","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:06:26Z","timestamp":1788242786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive model for ulcerative colitis therapeutic response using clinical indicators and peripheral blood T-cell subsets"],"prefix":"10.3389","volume":"17","author":[{"given":"Tian","family":"Pu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunru","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaf017","article-title":"Single-cell transcriptomic profile of innate cell populations in mesenteric lymph nodes of inflammatory bowel disease patients","volume":"31","author":"Wils","year":"2025","journal-title":"Inflammation Bowel Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"Stride-ii: an update on the selecting therapeutic targets in inflammatory bowel disease (stride) initiative of the International Organization for the Study of IBD (IOIBD)","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213041119","article-title":"Fxr mediates ilc-intrinsic responses to intestinal inflammation","volume":"119","author":"Fu","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.11.21263401","article-title":"Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease","volume":"14","author":"Letizia","year":"2022","journal-title":"EMBO Mol Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.903688","article-title":"Helper-like type-1 innate lymphoid cells in inflammatory bowel disease","volume":"13","author":"Coman","year":"2022","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.009","article-title":"Transcription factor-driven regulation of ilc1 and ilc3","volume":"43","author":"Schroeder","year":"2022","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-981-16-8387-9_7","article-title":"Innate lymphoid cells and inflammatory bowel disease","volume":"1365","author":"Peng","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.760198","article-title":"Sustained post-developmental t-bet expression is critical for the maintenance of type one innate lymphoid cells in vivo","volume":"12","author":"Schroeder","year":"2021","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.3390\/ijms22147618","article-title":"Innate lymphoid cells in intestinal homeostasis and inflammatory bowel disease","volume":"22","author":"Saez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5334\/jbsr.4117","article-title":"The evolving role of imaging in inflammatory bowel disease (Crohn\u2019s disease): From diagnosis to innovation","volume":"109","author":"De Kock","year":"2025","journal-title":"J Belgian Soc Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf107","article-title":"Ecco-esgar-esp-ibus guideline on diagnostics and monitoring of patients with inflammatory bowel disease: Part 2: uc scores and general principles and technical aspects","volume":"19","author":"Yanai","year":"2025","journal-title":"J Crohn's Colitis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100967","article-title":"Nk cell and ilc heterogeneity in colorectal cancer. New perspectives from high dimensional data","volume":"80","author":"Pietropaolo","year":"2021","journal-title":"Mol Aspects Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.656745","article-title":"Innate lymphoid cells as regulators of epithelial integrity: Therapeutic implications for inflammatory bowel diseases","volume":"8","author":"Schulz-Kuhnt","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa316","article-title":"Crohn's disease is associated with activation of circulating innate lymphoid cells","volume":"27","author":"Mazzurana","year":"2021","journal-title":"Inflammation Bowel Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073323","article-title":"Changes in t lymphocytes and cytokines after anti-tnf treatment in pediatric inflammatory bowel disease: Association with response to pharmacologic therapy","volume":"26","author":"Zapata-Cobo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","article-title":"Predictors of primary response to biologic treatment [anti-tnf, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: From basic science to clinical practice","volume":"14","author":"Gisbert","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05486-w","article-title":"Early response to corticosteroid and baseline c-reactive protein predicts outcomes in children with moderate to severe ulcerative colitis","volume":"64","author":"Deva Rajoo","year":"2019","journal-title":"Dig Dis Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1741596","article-title":"Antibiotics administration during weaning ameliorates intestinal mucosal inflammation in adult mice and their offspring","volume":"17","author":"Cao","year":"2026","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70446","article-title":"Magnesium deficiency accelerates gut aging and increases susceptibility to colitis","volume":"25","author":"Zhang","year":"2026","journal-title":"Aging Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"jjag025","DOI":"10.1093\/ecco-jcc\/jjag025","article-title":"Real-world evidence on medication patterns in inflammatory bowel disease the first decade after diagnosis","volume":"20","author":"Christensen","year":"2026","journal-title":"J Crohns Colitis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12876-025-03603-w","article-title":"Correlation and diagnostic significance of cd4 t cell subsets and nlrp3 inflammasome in ulcerative colitis: the role of the nlrp3\/t-bet\/gata3 axis","volume":"25","author":"Hu","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.21037\/atm-25-141","article-title":"Impact of tobacco use on inpatient outcomes in inflammatory bowel disease: a retrospective matched cohort study","volume":"14","author":"Eldesouki","year":"2026","journal-title":"Ann Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2196\/71944","article-title":"Prognostic prediction models for ulcerative colitis: Systematic review and meta-analysis","volume":"27","author":"Bu","year":"2025","journal-title":"J Med Internet Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10238-025-01601-6","article-title":"Prediction of vedolizumab efficacy in ulcerative colitis: a nomogram incorporating pathological feature and serological marker","volume":"25","author":"Wang","year":"2025","journal-title":"Clin Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18190","article-title":"A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis","volume":"60","author":"Croft","year":"2024","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1905745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:06:27Z","timestamp":1788242787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1905745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2026.1905745"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1905745","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1905745"}}